24 Oct 2017 | 11:24 AM
 

Aarti Drugs Ltd. Share Price Live (BSE)
0

BSE Code: 524348 | NSE Symbol: AARTIDRUGS
534.71
0.20
(0.04 %)
24 Oct 2017 | 11:12 AM
Change company
  • Open (Rs)
    533.05
  • Prev. close (Rs.)
    534.50
  • High (Rs.)
    536.00
  • Low (Rs.)
    520.00
  • 52W H (Rs.)
    684.00
  • 52W L (Rs.)
    456.25
  • Volume
    225
  • MCap (Rs in Cr.)
    1,275.64
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
33.77
Operating Margin (%)
15.81
Gross Profit Margin (%)
12.60
Net Profit Margin (%)
6.71
Total Debt/Equity
1.09
Dividend payout Ratio (Net Profit)
0.00
Earning Retention Ratio
100.00

News

18 Aug 2017 - 18:52:00-The company reported standalone net profit of Rs 10...
21 May 2015 - 11:17:00-Shares of Aarti Drugs fell over 6 per cent in early trade on Bombay Stock Exchange (BSE) as its resu...
25 Mar 2015 - 16:47:00-Aarti Drugs which is engaged in pharmaceutical business announced that the US Food and Drug Administ...
24 Mar 2015 - 12:08:00-Shares of Aarti Drugs fell nearly 54 per cent in early trade on Bombay Stock Exchange (BSE) after th...

Announcements

13-Oct-2017
Aarti Drugs Ltd - Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2
10-Oct-2017
Aarti Drugs Ltd - Compliance Certificate For The Half Year Ended 30Th September 2017
10-Oct-2017
Aarti Drugs Ltd - Shareholding for the Period Ended September 30 2017
03-Oct-2017
Aarti Drugs Ltd - Statement Of Investor Complaints For The Quarter Ended 30Th September 2017
21-Aug-2017
Aarti Drugs Ltd - Amendments to Memorandum & Articles of Association

Religare Research

23 Oct 2017 | 07:25 PM
• Gold prices rebounded from two month lows on Friday as fresh concerns over tensions with North Kor...
23 Oct 2017 | 06:30 PM
Tech Stars, comprises our 2 top stock picks filtered on the basis of momentum from our coverage univ...
23 Oct 2017 | 10:46 AM
Indian rupee closed little changed with marginal losses against the US dollar as traders avoided tak...
23 Oct 2017 | 09:33 AM
Gold dipped as dollar gained after US Senate cleared tax reform hurdle  Crude oil rose on tighter f...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
4,21,002 23.92 38.02 0.41
4,21,002 23.92 62.61 0.41
4,21,002 23.92 64.58 0.42
4,21,002 23.92 39.21 0.41
1,69,941 9.65 12.29 -0.46

Shareholding Pattern

       
Promotors62.49%
Mutual Funds/UTI3.68%
FI/Banks0.81%
Insurance0.81%
FII0.68%
Government0.00%
Others3.85%

Peer Group

Company Intraday Graph
 Merck Ltd.
1,154.90(-0.31)
3302
 Neuland Laboratories Ltd.
1,107.95(0.35)
3578
 Kovai Medical Center and Hospital Ltd.
1,104.50(1.18)
11816
 Hester Biosciences Ltd.
1,080.00(-0.25)
3572

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Aarti Drugs Ltd.25.30-26.20-54.25
NIFTY(S&P CNX)348.15256.201,002.80
BSE SENSEX954.67335.432,925.46
BSE 500573.40473.571,395.54

Corporate Details

Key Personal
Chandrakant V Gogri
Chairman Emeritus
Harit P Shah
Whole Time Director
Harshit M Savla
Joint Managing Director
Key Address
Registered Office
Plot No. N-198 MIDC Tarapur Village - Pamtermbhi,Palghar District,Maharashtra

Tel:022-24072249 24019025, Fax:022-24073462 25653234

investorrelations@aartidrugs.com
http://www.aartidrugs.com
Registrar Office
In House